Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging drugs for alpha-1-antitrypsin deficiency.

Expert opinion on emerging drugs - 1 Dec 2010

Stockley Robert A

Abstract excerpt

IMPORTANCE OF THE FIELD: Alpha-1-antitrypsin (A1AT) deficiency is a common genetic condition that predisposes individuals to the development of chronic obstructive pulmonary disease (COPD) as a direct result of damage caused to the lung by proteolytic enzymes released by migrating neutrophils. The lack of A1AT fails to control these enzymes and in the most common genetic deficiency (Pi Z) is due to accumulation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Drug Design

Share to Inflammation

Share to Liver Diseases

Share to Pulmonary Disease, Chronic Obstructive

Source

Identifiers

PMID: 20716026
DOI: 10.1517/14728214.2010.512287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging drugs for alpha-1-antitrypsin deficiency.PMID 20716026Read ↗

Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging diseaseSemantic proximity Read ↗

Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis.Semantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

A Review of α1-Antitrypsin DeficiencySemantic proximity Read ↗

α1-Antitrypsin deficiency.Semantic proximity Read ↗

Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlookSemantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicineSemantic proximity Read ↗

Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency: outstanding questions and future directionsSemantic proximity Read ↗

Alpha one antitrypsin deficiency: from gene to treatment.Semantic proximity Read ↗

[Alpha-1-antitrypsin deficiency].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.